![Michael Solomon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Solomon
Direktör/Styrelseledamot på
PROTARA THERAPEUTICS, INC.
Förmögenhet: 102 290 $ per 2026-08-31
Profil
Michael E.
Solomon was the founder of Epizyme, Inc. (2007) and served as Vice President-Discovery.
Current jobs include Independent Director at Protara Therapeutics, Inc. (2018) and Director at ValenzaBio, Inc. (2021).
Former jobs include Chief Executive Officer & Director at Ribometrix, Inc. (2017-2025), Director at ArTara Subsidiary, Inc., Principal at Millennium Pharmaceuticals, Inc., Chief Business Officer at Link Medicine Corp.
(2009-2012), Senior Associate at Banc of America Securities LLC, Venture Capital at SV Health Investors LLC (2016-2018), Chief Operating Officer at Ember Therapeutics, Inc. (2012-2015), Chief Operating Officer at Decibel Therapeutics, Inc. (2015-2016), and Vice President-Discovery at Hypnion, Inc. (2003-2007).
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Massachusetts.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-15 | 26 500 ( 0,04 % ) | 102 290 $ | 2026-08-31 |
Aktiva positioner av Michael Solomon
| Företag | Position | Start |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-01-01 |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Direktör/Styrelseledamot | 2021-06-01 |
Tidigare kända positioner av Michael Solomon
| Företag | Position | Slut |
|---|---|---|
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Verkställande Direktör | 2025-01-09 |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Företagsledare/Principal | 2018-12-01 |
| DECIBEL THERAPEUTICS, INC. | Verksamhetschef | 2016-01-01 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Verksamhetschef | 2015-01-01 |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Företagsledare/Principal | 2012-01-01 |
Michael Solomons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Health Technology |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Finance |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Health Technology |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
